Open AccessPharmacokinetics and Dialytic Clearance of Isavuconazole during In Vitro and In Vivo Continuous Renal Replacement Therapy
Author(s) -
Mark Biagi,
David A. Butler,
X. Tan,
Samah Qasmieh,
K. Tejani,
Shitalben Patel,
Ryan Rivosecchi,
M. Hong Nguyen,
Cornelius J. Clancy,
Ryan K. Shields,
Eric Wenzler
Publication year - 2019
Publication title -
antimicrobial agents and chemotherapy
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.07
H-Index - 259
eISSN - 1070-6283
pISSN - 0066-4804
DOI - 10.1128/aac.01085-19
Subject(s) - cmin , pharmacokinetics , cmax , in vivo , renal replacement therapy , pharmacology , medicine , renal function , chemistry , biology , microbiology and biotechnology
The pharmacokinetics (PK) and dialytic clearance of isavuconazolein vitro and in 7 solid-organ transplant patients undergoing continuous renal replacement therapy (CRRT) were evaluated.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom